Treatment of Relapsed or Refractory Acute Myeloblastic Leukemia

NCT01435343 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloblastic Leukemia

Interventions

DRUG: fludarabine
DRUG: Idarubicin
DRUG: cytarabine
DRUG: G-CSF
DRUG: plerixafor

Sponsor

PETHEMA Foundation